Product NDC: | 76310-024 |
Proprietary Name: | Foscavir |
Non Proprietary Name: | foscarnet sodium |
Active Ingredient(s): | 24 mg/mL & nbsp; foscarnet sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76310-024 |
Labeler Name: | Clinigen Healthcare Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020068 |
Marketing Category: | NDA |
Start Marketing Date: | 20120709 |
Package NDC: | 76310-024-25 |
Package Description: | 10 CARTON in 1 CARTON (76310-024-25) > 1 BOTTLE in 1 CARTON > 250 mL in 1 BOTTLE |
NDC Code | 76310-024-25 |
Proprietary Name | Foscavir |
Package Description | 10 CARTON in 1 CARTON (76310-024-25) > 1 BOTTLE in 1 CARTON > 250 mL in 1 BOTTLE |
Product NDC | 76310-024 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | foscarnet sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120709 |
Marketing Category Name | NDA |
Labeler Name | Clinigen Healthcare Ltd. |
Substance Name | FOSCARNET SODIUM |
Strength Number | 24 |
Strength Unit | mg/mL |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Pyrophosphate Analog [Chemical/Ingredient],Pyrophosphate Analog DNA Polymerase Inhibitor [EPC] |